Skip to main content

CSCC: the role of cemiplimab in clinical data and clinical practice

By 4 Dicembre 2020Maggio 12th, 2021No Comments
CongressiTemi

Immunotherapy in squamous cell carcinoma (CSCC): which is the role of cemiplimab in clinical data and clinical practice? We asked it to Dirk Schadendorf, Director of Clinic for Dermatology – Essen University Hospital during the IMMUNOTHERAPY & MELANOMA Bridge Congress 2020.